‹ Back
GHK-Cu, Copper Tripeptide-1
The story
In 1973 Loren Pickart, working with Marvin Thaler in San Francisco, found a small factor in young human plasma that kept old liver cells alive and working like young ones. He identified it as Gly-His-Lys and in 1980 showed that it works by carrying copper into cells. Through the 1980s and 1990s, French teams in Reims under Francois-Xavier Maquart showed it makes fibroblasts build collagen and helps rat wounds fill with new tissue. Later gene studies found it shifts thousands of human genes toward repair. Russian dermatologists in Moscow have reviewed its role in skin regeneration and use it in clinical skin care.
Sources
Read the original sources
- Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver (Abstract · checked 2026-10-13)
- Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells (Abstract · checked 2026-10-13)
- Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. (Maquart · 1988 · Abstract; full methods not assumed · checked 2026-10-13)
- GHK-Cu: rat wound chamber study (1993 · Published abstract · checked 2026-10-08)
- GHK and DNA: resetting the human genome to health (Abstract · checked 2026-10-13)
- The role of copper tripeptide (GHK-Cu) in the process of skin regeneration, Polonskaia, Shatokhina, Kruglova, Pharmateca 2020 (Moscow) (Abstract · checked 2026-10-13)